01652 FUSEN PHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.60X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 21.4% | Net Margin | N/A |
| Total Debt/Equity | 103.8% | Return on Equity | N/A |
| Price/Book | 0.71X | Return on Assets | N/A |
| (HKD 0.380) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -200.77 | -39.98 | -38.80 | 20.36 | 83.23 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -402.1 | -3.1 | -290.6 | -75.5 | +39.3 |
| Earnings Per Share (HKD) | -0.271 | -0.053 | -0.051 | 0.027 | 0.106 |
| Earnings Per Share Growth (%) | -410.0 | -3.7 | -293.6 | -75.0 | +41.8 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | 0.011 | 0.011 |
| P/E* (X) | N/A | N/A | N/A | 14.34 | 3.59 |
| Yield (%) | N/A | N/A | N/A | 2.89 | 2.76 |
| Dividend Share (%) | N/A | N/A | N/A | 41.51 | 9.92 |
| Book NAV (HKD) | 0.532 | 0.828 | 0.908 | 1.046 | 1.011 |
| Auditors' Opinion | Unqualified # | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 111.286 | 196.322 | -43.3 | 336.437 |
| Operating Result | -28.01 | -43.895 | -36.2 | 36.56 |
| Associates | 5.285 | -1.43 | -469.6 | -13.664 |
| Profit Before Taxation | -22.725 | -45.325 | -49.9 | 22.896 |
| Taxation | 0.411 | -8.376 | -104.9 | 6.449 |
| Profit /( Loss) After Taxation | -23.136 | -36.949 | -37.4 | 16.447 |
| Minority Interests | 0 | -0.008 | -100.0 | -0.009 |
| Net Profit | -23.136 | -36.941 | -37.4 | 16.456 |
| Earnings Per Share () | -0.0343 | -0.0536 | -36.0 | 0.0235 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2025-08-29 | 2024-08-29 | NA | 2023-08-29 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
